Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-076724
Filing Date
2010-08-12
Accepted
2010-08-12 16:57:16
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d74686e10vk.htm 10-K 1396069
2 EX-10.37 d74686exv10w37.htm EX-10.37 69988
3 EX-10.38 d74686exv10w38.htm EX-10.38 12155
4 EX-10.51 d74686exv10w51.htm EX-10.51 471129
5 EX-23.1 d74686exv23w1.htm EX-23.1 1730
6 EX-31.1 d74686exv31w1.htm EX-31.1 9982
7 EX-31.2 d74686exv31w2.htm EX-31.2 10192
8 EX-32.0 d74686exv32w0.htm EX-32.0 7138
9 GRAPHIC d74686d7468601.gif GRAPHIC 13499
10 GRAPHIC d74686d7468602.gif GRAPHIC 2815
11 GRAPHIC d74686d7468603.gif GRAPHIC 253690
  Complete submission text file 0000950123-10-076724.txt   2352222
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

EIN.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-16633 | Film No.: 101011738
SIC: 2834 Pharmaceutical Preparations